Synonyms: compound 38 [PMID: 36533617] | RMC5552
Compound class:
Synthetic organic
Comment: RMC-5552 is a selective bi-steric inhibitor of mTORC1 [1]. Mechanistically it interacts with both the orthosteric and allosteric binding sites of mTOR, and inhibits phosphorylation of S6K and 4EBP1 (to provide anti-tumour activity) whilst sparing mTORC2-mediated effects on AKT signalling and glucose metabolism. It was developed for potential to treat mTORC1-activated tumours, and is an active clinical lead (Jan 2023).
|
|
Bioactivity Comments |
In cell-based assays RMC-5552 inhibits phosphorylation of S6K, 4EBP1 (downstream targets of the mTORC1 complex) and AKT (a mTORC2 downstream target) with IC50s of 0.14 nM, 0.48 nM and 19 nM respectively [1]. |